Product Wiki · Recalls · EU Safety Gate (RAPEX)

Pilka gumowa — recall A12/00981/24

EU Safety Gate (RAPEX) · Poland · 2024-04-26 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/00981/24
Date of alert
2024-04-26
Country / jurisdiction
Poland
Risk level
Serious risk
Risk type
Chemical
Brand
Gucio
Product category
Toys
Product type
Plastic ball
Barcode (EAN/GTIN)
5902884419464
Reported risk: Zabawka ma nadmierne stężenie ftalanu diizobutylu (DIBP) (zmierzone do 9,4% wagowo). Ten ftalan może szkodzić zdrowiu dzieci, powodując możliwe uszkodzenie ich układu rozrodczego. Produkt nie jest zgodny z rozporządzeniem REACH.
Action taken by the authority
Type of economic operator taking notified measure
Importer
Category of measure
Destruction of the product
Date of entry into force
15/03/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Pilka gumowa

Risk Description (original English): The toy has an excessive concentration of diisobutyl phthalate (DIBP) (measured value up to 9.4 % by weight). This phthalate may harm the health of children, causing possible damage to their reproductive system.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10012753

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.